Gene · 7155
Papers2,315
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,315
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural insights into the assembly of type IIA topoisomerase DNA cleavage-religation center. | Nucleic Acids Res | 2024 | 39077950 | PubTator, text mining | PubMed |
| R-loop resolution by ARIP4 helicase promotes androgen-mediated transcription induction. | Sci Adv | 2024 | 39028815 | PubTator, text mining | PubMed |
| Acridinedione-phthalimide conjugates: Intramolecular electron transfer and singlet oxygen generation studies for optical and photodynamic therapy applications. | Photochem Photobiol Sci | 2024 | 38937393 | PubTator, text mining | PubMed |
| Recent Advances in and Application of Fluorescent Microspheres for Multiple Nucleic Acid Detection. | Biosensors (Basel) | 2024 | 38920569 | PubTator, text mining | PubMed |
| Synthesis and antiproliferative evaluation of novel 3,5,8-trisubstituted coumarins against breast cancer. | Future Med Chem | 2024 | 38708686 | PubTator, text mining | PubMed |
| In Vitro Antibacterial, DPPH Radical Scavenging Activities, and In Silico Molecular Modeling of Isolated Compounds from the Roots of Clematis hirsuta. | Adv Pharmacol Pharm Sci | 2024 | 38562543 | PubTator, text mining | PubMed |
| Myeloperoxidase inhibition protects bone marrow mononuclear cells from DNA damage induced by the TOP2 poison anti-cancer drug etoposide. | FEBS Open Bio | 2024 | 38531625 | PubTator, text mining | PubMed |
| Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase IIβ in Human Leukemia K562 Cells: Generation of a Resistance Phenotype. | J Pharmacol Exp Ther | 2024 | 38508753 | PubTator, text mining | PubMed |
| Decoding chromatin states by proteomic profiling of nucleosome readers. | Nature | 2024 | 38448585 | PubTator, text mining | PubMed |
| A Comprehensive Review of Cancer Drug-Induced Cardiotoxicity in Blood Cancer Patients: Current Perspectives and Therapeutic Strategies. | Curr Treat Options Oncol | 2024 | 38372853 | PubTator, text mining | PubMed |
| Chromatin damage generated by DNA intercalators leads to degradation of RNA Polymerase II. | Nucleic Acids Res | 2024 | 38340348 | PubTator, text mining | PubMed |
| Loss of Adaptive DNA Breaks in Alzheimer's Disease Brains. | J Alzheimers Dis | 2024 | 38306051 | PubTator, text mining | PubMed |
| Targeting TOP2B as a vulnerability in aging and aging-related diseases. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38296114 | PubTator, text mining | PubMed |
| Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications. | Cells | 2024 | 38275816 | PubTator, text mining | PubMed |
| A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging. | NPJ Aging | 2024 | 38263284 | PubTator, text mining | PubMed |
| MDM2 provides TOP2 poison resistance by promoting proteolysis of TOP2βcc in a p53-independent manner. | Cell Death Dis | 2024 | 38263255 | PubTator, text mining | PubMed |
| Therapeutic Potential of Bipolar Androgen Therapy for Castration-Resistant Prostate Cancer: In Vitro and In Vivo Studies. | Biomedicines | 2024 | 38255286 | PubTator, text mining | PubMed |
| MicroRNAs Associated with a Bad Prognosis in Acute Myeloid Leukemia and Their Impact on Macrophage Polarization. | Biomedicines | 2024 | 38255226 | PubTator, text mining | PubMed |
| Enzymatic Processing of DNA-Protein Crosslinks. | Genes (Basel) | 2024 | 38254974 | PubTator, text mining | PubMed |
| Pyridoxamine Attenuates Doxorubicin-Induced Cardiomyopathy without Affecting Its Antitumor Effect on Rat Mammary Tumor Cells. | Cells | 2024 | 38247812 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7155/papers?page=6